86 results
Page 2 of 5
8-K
EX-1.1
4mv4aelnie qq
30 Mar 22
Soleno Therapeutics Announces Pricing of Approximately $15 Million Underwritten Public Offering
5:24pm
424B5
u9maizm0
30 Mar 22
Prospectus supplement for primary offering
5:21pm
424B5
33a88hewv27dp2
28 Mar 22
Prospectus supplement for primary offering
4:53pm
8-K
EX-99.1
veddus65gyo0
10 Nov 21
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results
4:16pm
8-K
EX-1.1
dxbvkg9 gwnsl4
16 Jul 21
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-99.1
jh8oz7
5 May 21
Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results
4:01pm
8-K
r52 fylg3qagqfdvc
13 Nov 20
Termination of a Material Definitive Agreement
4:02pm
8-K
EX-1.1
o0zhvr9 v2tqwg
26 Jun 20
Soleno Therapeutics Announces Pricing of $50 Million Public Offering of Common Stock
4:31pm
424B5
123kwamalxjjtmo3bt47
25 Jun 20
Prospectus supplement for primary offering
4:01pm
424B5
ic6bzd 3usw
23 Jun 20
Prospectus supplement for primary offering
4:06pm